IDEXX Laboratories, Inc.
Michael Lane (Executive Vice President) sells IDXX shares
AI-generated summary
Executive Vice President Michael Lane sold 3,978.944 shares of Common Stock in open-market sales for approximately $2,740,069.40 at an average price of $688.64 on November 4, 2026. After these transactions, the insider directly held 4,076 shares.
Key facts
- Insider
- Michael Lane · Executive Vice President
| Date | Transaction | Shares | Price | Value | Held after | Ownership |
|---|---|---|---|---|---|---|
| Nov 4, 2026 | S · open-market saleFootnotes F1 | −242.944 | $687.85 | $167,109.03 | 7,812 | Direct |
| Nov 4, 2026 | S · open-market sale | −2,059 | $689.70 | $1,420,092.30 | 5,753 | Direct |
| Nov 4, 2026 | S · open-market saleFootnotes F2 | −1,677 | $687.46 | $1,152,868.07 | 4,076 | Direct |
Footnotes
- F1 Includes a total of 31 shares purchased under the Issuer Employee Stock Purchase Plan on March 31, 2026, June 30, 2026 and September 30, 2026.
- F2 Represents the weighted average price of the shares sold ranging from a low of $687.0701 to a high of $687.50 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
- F3 Held by the reporting person's spouse in an IRA account. The reporting person disclaims beneficial ownership of the shares of common stock held by his spouse except to the extent of his pecuniary interest therein.
More IDXX filings
- 4
Filed Nov 5, 2026
- 4
Filed Nov 5, 2026
- 4
Filed Nov 5, 2026
- 144/A
Filed Nov 5, 2026
- 144
Filed Nov 4, 2026
- 144
Filed Nov 4, 2026
Not investment advice. Summaries can contain errors; the SEC filing is the official record.